Chinese Journal of Pharmaceuticals
|
2026, 57(6): 724-729
• Pharmaceutical Management & Information •
Analysis and Discussion of Key Consideration for Segmented Manufacturing of Biological Products from the Perspective of Registration Inspection
Full
Haitao SHI1, Bo SHEN1, *, Bin CHENG1, Jingpeng YANG2, Benxia HE1, Xiaorui CAO1, Chao LI1
Affiliations
- 1.Guangdong-Hong Kong-Macao Greater Bay Area Center for Drug Evaluation and Inspection of NMPA, Shenzhen 518000
- 2.Center for Food and Drug Inspection of NMPA, Beijing 100010
Published: 2026-06-10
doi: 10.16522/j.cnki.cjph.2026.06.015
Outline
史海涛, 沈波, 成斌, 杨敬鹏, 何本霞, 曹晓瑞, 李超.
注册核查视角下生物制品分段生产关注点的分析与探讨.
中国医药工业杂志,
2026
, 57
(6)
: 724
-729
.
DOI: 10.16522/j.cnki.cjph.2026.06.015
Haitao SHI, Bo SHEN, Bin CHENG, Jingpeng YANG, Benxia HE, Xiaorui CAO, Chao LI.
Analysis and Discussion of Key Consideration for Segmented Manufacturing of Biological Products from the Perspective of Registration Inspection[J].
Chinese Journal of Pharmaceuticals,
2026
, 57
(6)
: 724
-729
.
DOI: 10.16522/j.cnki.cjph.2026.06.015
Year 2026 volume 57 Issue 6
149
40
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.06.015
- Receive Date:2026-01-08
- Online Date:2026-11-05
- Published:2026-06-10